Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-24-000065

Chief Operating Officer returned 1,130 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Castle Jeremy Chief Operating Officer 2024-12-03 Returned to the company −1,130 $0.16 $181 81,330 D: show line 1 in the form
Loading xslF345X05/wk-form4_1733432530.xml…